Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02683473 · ClinicalTrials.gov registry record

Measurement of Energy Metabolism in Infants

A clinical trial of Infant Development and Infant Overnutrition, sponsored by Pennington Biomedical Research Center.

Recruiting
Registry status
70
Enrollment target
1
Study location

NCT02683473: Recruiting study of Infant Development and Infant Overnutrition, sponsored by Pennington Biomedical Research Center.

NCT02683473 is a study of Infant Development and Infant Overnutrition that is actively recruiting participants, run by Pennington Biomedical Research Center. The registered enrollment target is 70 participants, below the 401-participant average among 30 other Infant Development trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02683473, a study of Infant Development and Infant Overnutrition, is actively recruiting participants, sponsored by Pennington Biomedical Research Center.

RECRUITING
Registry status
70 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to measure energy expenditure during the first 3 months of life in infants.

Primary Outcome

Energy expenditure by infant metabolic chamber measured twice about 1 week apart for test re-test reliability in infants aged 1-3 months.

Study Locations (1)

Louisiana

  • Pennington Biomedical Research Center - Baton Rouge

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2016-03-16
Est. Completion 2027-06-30

What NCT02683473 shows while recruiting

NCT02683473 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 401-participant average among 30 other Infant Development trials with a reported enrollment target (83% lower).

The record links to 2 conditions, with Infant Development appearing as the primary indexed condition, and to 0 interventions.

NCT02683473 reports a single indexed study location in Louisiana.

Frequently Asked Questions

What is clinical trial NCT02683473 about?

NCT02683473 is a clinical study titled "Measurement of Energy Metabolism in Infants". The purpose of this study is to measure energy expenditure during the first 3 months of life in infants.

What is the current status of trial NCT02683473?

This trial is currently recruiting. The enrollment target is 70 participants. The study started on 2016-03-16. Estimated completion is 2027-06-30.

What conditions does trial NCT02683473 study?

This clinical trial studies the following conditions: Infant Development, Infant Overnutrition.

Who is sponsoring clinical trial NCT02683473?

This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02683473 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infant Development

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02683473's enrollment target sits among peer trials

70 23rd of 30 higher than 8 of 30 other Infant Development trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Infant Development trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00969111 · 70 participants · NA

    Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy

  • NCT01712620 · 70 participants · Phase 2

    Spironolactone for Pulmonary Arterial Hypertension

  • NCT02143830 · 70 participants · Phase 2

    HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy

  • NCT02601339 · 70 participants

    NIRS Monitoring in Premature Infants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02683473, the US trial registry maintained by the National Library of Medicine. NCT02683473 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.